beta-lactams has been researched along with Respiratory Tract Infections in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (15.05) | 18.7374 |
1990's | 8 (8.60) | 18.2507 |
2000's | 38 (40.86) | 29.6817 |
2010's | 27 (29.03) | 24.3611 |
2020's | 6 (6.45) | 2.80 |
Authors | Studies |
---|---|
Ahmed, A; Anwaar, F; Ghumman, NZ; Ijaz, M; Javed, MU; Muzammil, I; Rasheed, H; Raza, A | 1 |
de Jong, MD; Doan, KV; Minh, NNQ; Phuong, PN; Pouplin, T; van Doorn, HR; Van Toi, P | 1 |
Aboulatta, L; Noma, H; Sasaki, T; Sugita, H; Wakabayashi, H | 1 |
Abdul-Aziz, MH; Portunato, F; Roberts, JA | 1 |
Brun-Buisson, C; Caserio-Schönemann, C; Cheysson, F; Guillemot, D; Le Fouler, L; Opatowski, L; Pontais, I; Watier, L | 1 |
Holland, P; Jahnke, N | 1 |
Baba, T; Hagiwara, E; Kitamura, H; Komatsu, S; Ogura, T; Sekine, A; Shinohara, T | 1 |
Bousquet-Melou, A; Ferran, AA; Lacroix, MZ; Toutain, PL; Vasseur, MV | 1 |
Alzghari, SK; Blanco, DD; Hager, JD; Kuntz, KS; Lee, YR; Miller, PD | 1 |
Ealand, CS; Kana, BD; Machowski, EE | 1 |
Brauns, J; Höltig, D; Kadlec, K; Kipschull, K; Müller, P; Nathaus, R; Niemann, L; Schäkel, F; Schwarz, S; Wendt, M | 1 |
Månsson, V; Resman, F; Riesbeck, K; Thegerström, J | 1 |
Essig, A; Grüner, B; Hagemann, JB; Haverkamp, S; Kuchenbauer, F | 1 |
Coughlin, O; Kokai-Kun, JF; Le, C; Roberts, T; Sliman, J; Stevenson, R; Wacher, VJ; Whalen, H | 1 |
Barceló, IM; Jordana-Lluch, E; Juan, C; Oliver, A; Sánchez-Diener, I; Torrens, G; Zamorano, L | 1 |
Gurov, AV; Muzhichkova, AV | 1 |
Bowman, C; Charlett, A; Cookson, B; Davey, P; Fleet, E; Gopal Rao, G; Patel, B | 1 |
Elphick, HE; Jahnke, N | 1 |
Belova, VV; Bulovskaia, LN; Erbasskaia, AV; Govorova, LV; Ivanova, VV | 1 |
Falagas, ME; Trigkidis, KK; Vardakas, KZ | 1 |
Hartmann, M; Honscha, W; Käsbohrer, A; Kreienbrock, L; Merle, R; Ottilie, H; van Rennings, L; von Münchhausen, C | 1 |
Gorelik, AL; Karaseva, OV; Katosova, LK; Kryzhanovskaya, OA; Lazareva, AV; Mayanskiy, NA; Ponomarenko, OA | 1 |
Angulo-Barturen, I; Arthur, M; Ballell, L; Barros-Aguirre, D; Dhar, N; Diacon, AH; García-Pérez, A; Hugonnet, JE; Lelievre, J; McKinney, JD; Rullas, J | 1 |
Elborn, JS; Gilpin, DF; Hatch, J; McGrath, SJ; McIlreavey, L; Muhlebach, MS; Sherrard, LJ; Tunney, MM; Wolfgang, MC | 1 |
Callens, B; Catry, B; de Kruif, A; Dewulf, J; Haesebrouck, F; Maes, D; Opsomer, G; Pardon, B; Vanrobaeys, M | 1 |
Aktas, Z; Altinkanat, G; Altun, B; Aydemir, S; Gorur, H; Gunaydin, M; Gur, D; Karadag, A; Kayacan, C; Morrissey, I; Soyletir, G; Torumkuney, D; Tunger, A | 1 |
Burgess, DR; Burgess, DS; Martin, CA; Rutter, WC; Thompson, RZ | 1 |
Di Maggio, T; Docquier, JD; Landini, G; Pallecchi, L; Rossolini, GM; Sergio, F | 1 |
Elphick, HE; Scott, A | 1 |
Doern, GV; Kuti, JL; Nicolau, DP; Pichichero, ME | 1 |
Cohen, R | 1 |
Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
Abe, T; Azagami, S; Bamba, M; Cho, H; Hojo, H; Jozaki, K; Koizumi, Y; Nakao, A; Nonoyama, M; Ojima, T; Ozaki, A; Sunakawa, K; Yokota, T | 1 |
Reed, MD | 1 |
Brook, I | 1 |
Aoki, N; Kohno, S; Niki, Y; Watanabe, A | 1 |
Aguilar, L; Alou, L; Coronel, P; Gimenez, MJ; Granizo, JJ; Maestre, JR; Mateo, M; Méndez, ML; Prieto, J | 1 |
Lode, H | 2 |
An, S; Chen, J; Chen, Y; Gao, Z; Li, J; Wang, H; Wang, Q; Wang, X; Wang, Z; Xu, X; Yan, X; Yang, J | 1 |
Bebrone, C; Bennink, S; Bogaerts, P; Delbrück, H; Glupczynski, Y; Hoffmann, KM; Kupper, MB; Rezende de Castro, R | 1 |
Blosser-Middleton, RS; Critchley, IA; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C | 1 |
Hernández, S; Llor, C; Reig, R | 1 |
Gopal Rao, G; Mahankali Rao, CS; Starke, I | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Sakata, H | 1 |
Amyes, AK; Amyes, SG; Walsh, F | 1 |
Aguado-García, JM; Lumbreras-Bermejo, C; Martín-Herrero, JE | 1 |
Brown, SD; Stratton, CW | 1 |
Debbia, EA; Gualco, L; Marchese, A; Schito, AM; Schito, GC | 1 |
Ardito, F; Blandino, G; Fadda, G; Fontana, R; Lo Cascio, G; Marchese, A; Marchetti, F; Nicoletti, G; Schito, GC | 1 |
Alhambra, A; Alós, JI; Gómez-Garcés, JL; Hernáiz, C | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Furuno, JP; Harnett, JP; Langenberg, P; McGregor, JC; Metlay, JP; Perencevich, EN; Wilson, J; Zhu, J | 1 |
Dalhoff, A; Schaper, KJ; Schubert, S | 1 |
Caccamo, F; Catania, MR; Costanzo, R; Iauk, L; Musumeci, R; Puglisi, S; Speciale, A | 1 |
Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH | 1 |
Farrell, DJ; Sunakawa, K | 1 |
Del Mar, C | 1 |
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM | 1 |
Cerdá-Zolezzi, P; Durán, E; Gómez-Lus, R; Goñi-Cepero, P; Millán-Laplana, L; Oca, M; Rubio-Calvo, C | 1 |
Joseph, J; Rodvold, KA | 1 |
Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
Lundberg, C | 1 |
Schreiner, A | 1 |
Cole, P; Roberts, DE | 1 |
Matsumoto, K; Nagatake, T; Noguchi, Y; Rikitomi, N; Uzuka, Y | 1 |
Avery, GS; Brogden, RN; Carmine, A; Heel, RC; Morley, PA; Speight, TM | 1 |
Edelstein, PH; Meyer, RD; Pasiecznik, KA; Yasui, VK | 1 |
Cahen, P; Coustère, C; de Blic, J; Delacourt, C; Gaillard, JL; Le Bourgeois, M; Lenoir, G; Scheinmann, P; Silly, C | 1 |
Akita, H; Goshima, T; Ishihara, T; Iwai, N; Iwata, S; Kanemura, H; Kato, T; Kusumoto, Y; Meguro, H; Nakamura, H; Nakashima, M; Satoh, Y; Sunakawa, K; Terashima, I; Toyonaga, Y; Yokota, T | 1 |
Harada, H; Kawakami, K; Maruyama, I; Mogi, A; Narahara, S; Nishi, JI; Yoshinaga, M | 1 |
Chang, BJ; McGregor, K; Mee, BJ; Riley, TV | 1 |
Arata, J; Moritono, S; Saito, A | 1 |
Abdel-Rahman, EM; Dixon, RA; Ismael, NA | 1 |
Chevalier, A; Choutet, P; Garo, B; Germaud, P; Régnier, B; Vuittenez, F | 1 |
Sidorenko, SV | 1 |
Capper, TP; du Plessis, M; Klugman, KP | 1 |
Dajani, AS | 1 |
Friedland, I; Jiang, Q; Legua, P; Lema, J; Moll, J; Woods, G | 1 |
Auckenthaler, R | 1 |
Joly, J; Kraytman, M; Ninane, G; Piot, P | 1 |
Abe, T; Imaizumi, M; Kondo, D; Nishimura, M; Ojika, T; Sakakibara, M; Watanabe, H | 1 |
Barrett, MS; Ephtimios, IE; Jones, RN; Wenzel, RP | 1 |
Bryce, E; Cimolai, N | 1 |
Bingen, E; Lambert-Zechovsky, N; Lemer, G; Mariani-Kurkdjian, P; Sauzeau, C | 1 |
Lietman, PS | 1 |
Eliasson, I; Kamme, C | 1 |
Fukumoto, K; Kondo, M; Maekawa, N; Nakanishi, M; Nishino, T; Otsuki, M; Saji, Y; Tanaka, M; Tanino, T; Yoshikawa, T | 1 |
Aoyagi, M; Isotani, S; Kawabata, H; Maekawa, N; Moriguchi, T; Nakanishi, M; Nishino, T; Otsuki, M; Tanaka, M; Tanino, T | 1 |
Nagatake, T | 1 |
Maki, DG; Nichols, L | 1 |
19 review(s) available for beta-lactams and Respiratory Tract Infections
Article | Year |
---|---|
Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Data Management; Humans; Infusion Pumps; Length of Stay; Middle Aged; Pseudomonas; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2020 |
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Cystic Fibrosis; Drug Monitoring; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Severity of Illness Index | 2020 |
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2021 |
Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactams; Critical Illness; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Respiratory Tract Infections; Retrospective Studies | 2018 |
β-lactam resistance: The role of low molecular weight penicillin binding proteins, β-lactamases and ld-transpeptidases in bacteria associated with respiratory tract infections.
Topics: Aminoacyltransferases; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Molecular Weight; Penicillin-Binding Proteins; Respiratory Tract Infections | 2018 |
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2014 |
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome | 2015 |
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2000 |
Infections of the upper respiratory tract, head, and neck. The role of anaerobic bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Fluoroquinolones; Humans; Respiratory Tract Infections; Risk Factors; Tetracycline | 2000 |
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Administration Schedule; Drug Prescriptions; Emergency Service, Hospital; European Union; Fluoroquinolones; Government Agencies; Humans; Macrolides; Product Surveillance, Postmarketing; Respiratory Tract Infections; Safety; United States; United States Food and Drug Administration | 2010 |
[Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; beta-Lactams; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2004 |
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome | 2008 |
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
Topics: Amoxicillin; Animals; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Half-Life; Humans; Intestinal Absorption; Mice; Respiratory Tract Infections; Sexually Transmitted Diseases; Tissue Distribution; Urinary Tract Infections | 1981 |
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Respiratory Tract Infections | 1998 |
[Oral beta-lactam antibiotics in the treatment of respiratory tract infections].
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Community-Acquired Infections; Humans; Penicillins; Respiratory Tract Infections | 2001 |
Beta-lactam resistance: clinical implications for pediatric patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Community-Acquired Infections; Cross Infection; Humans; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2002 |
Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Respiratory Tract Infections | 2002 |
[Branhamella infection].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Humans; Neisseriaceae; Respiratory Tract Infections | 1985 |
7 trial(s) available for beta-lactams and Respiratory Tract Infections
Article | Year |
---|---|
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Recombinant Proteins; Respiratory Tract Infections; Treatment Outcome | 2019 |
Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Inappropriate Prescribing; Long-Term Care; Male; Nursing Homes; Pilot Projects; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections | 2014 |
Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Clostridioides difficile; Community-Acquired Infections; Diarrhea; Female; Humans; Levofloxacin; Male; Ofloxacin; Prospective Studies; Respiratory Tract Infections | 2003 |
Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Serum Bactericidal Test; Sputum; Treatment Outcome | 1995 |
[Clinical evaluation of faropenem against infections in pediatric fields].
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Diarrhea; Dosage Forms; Drug Therapy, Combination; Female; Humans; Infant; Lactams; Male; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections | 1997 |
Safety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
Topics: Aged; Anesthetics, Local; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Double-Blind Method; Ertapenem; Female; Humans; Injections, Intramuscular; Lactams; Lidocaine; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious | 2002 |
Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Clinical Trials as Topic; Cystic Fibrosis; Humans; Infant, Newborn; Lung Diseases; Respiratory Tract Infections | 1988 |
67 other study(ies) available for beta-lactams and Respiratory Tract Infections
Article | Year |
---|---|
Molecular evidence of β-lactam resistant Staphylococcus aureus in equids with respiratory tract infections: Frequency and resistance modulation strategy.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Investigation of early antibiotic use in pediatric patients with acute respiratory infections by high-performance liquid chromatography.
Topics: Acute Disease; Adolescent; beta-Lactams; Child; Child, Preschool; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Infant; Infant, Newborn; Limit of Detection; Linear Models; Prescription Drug Overuse; Reproducibility of Results; Respiratory Tract Infections | 2020 |
Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Bronchiolitis; Bronchitis; Child, Preschool; Emergency Service, Hospital; France; Humans; Inappropriate Prescribing; Influenza, Human; Macrolides; Outpatients; Pneumonia; Practice Patterns, Physicians'; Respiratory Tract Infections; Seasons; Virus Diseases | 2021 |
Ten-Year Trends and Clinical Relevance of the Antimicrobial Resistance Genotype in Respiratory Isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Polymerase Chain Reaction; Respiratory Tract Infections; Streptococcus pneumoniae | 2017 |
Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice.
Topics: Animals; Anti-Infective Agents; beta-Lactams; Female; Mice; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Respiratory Tract Infections | 2017 |
Antimicrobial susceptibility and genetic relatedness of respiratory tract pathogens in weaner pigs over a 12-month period.
Topics: Animals; Anti-Infective Agents; Bacteria; beta-Lactams; Bordetella bronchiseptica; Bordetella Infections; Drug Resistance, Multiple, Bacterial; Lincosamides; Macrolides; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida; Respiratory Tract Infections; Streptococcal Infections; Streptococcus suis; Swine; Swine Diseases; Tetracycline; Weaning | 2018 |
Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Pneumonia; Propensity Score; Respiratory Tract Infections; Retrospective Studies; Sweden; Young Adult | 2018 |
Pulmonary Campylobacter concisus infection in an immunocompromised patient with underlying mucormycosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Campylobacter; Campylobacter Infections; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lung Abscess; Macrolides; Male; Mucormycosis; Quinolones; Respiratory Tract Infections | 2018 |
In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall-Targeting Immunity.
Topics: Animals; Bacteremia; Bacterial Load; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ceftazidime; Cell Wall; Disease Models, Animal; Female; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Peptidoglycan; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Survival Analysis; Treatment Outcome; Virulence | 2019 |
[Pharmacoepidemiological analysis of outpatient-based practice of antibacterial therapy of ENT organ infections].
Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Macrolides; Otorhinolaryngologic Diseases; Outpatients; Penicillins; Pharmacoepidemiology; Respiratory Tract Infections; Russia | 2013 |
[Efficiency of antibiotics in children with acute respiratory infection complicated by pneumonia dependent on the acetylation type in the Far North regions].
Topics: Acetylation; Acetyltransferases; Anti-Bacterial Agents; beta-Lactams; Biotransformation; Child; Child, Preschool; Cold Climate; Ethnicity; Female; Gentamicins; Humans; Male; Pneumonia, Bacterial; Polymorphism, Genetic; Respiratory Tract Infections; Russia; Treatment Outcome | 2014 |
Cross-sectional study on antibiotic usage in pigs in Germany.
Topics: Age Factors; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactams; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Female; Germany; Macrolides; Male; Reproductive Tract Infections; Respiratory Tract Infections; Retrospective Studies; Sulfadoxine; Swine; Tetracyclines; Trimethoprim | 2015 |
[Monitoring and antibiotic resistance profile of tracheal aspirate microbiota in ICU children with severe craniocerebral trauma].
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child; Colistin; Craniocerebral Trauma; Cross Infection; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Humans; Intensive Care Units, Pediatric; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Trachea; Trauma Severity Indices | 2014 |
Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Dipeptidases; Disease Models, Animal; Drug Therapy, Combination; GPI-Linked Proteins; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Respiratory Tract Infections; Staphylococcal Infections; Tuberculosis | 2015 |
Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftazidime; Child; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Prevotella; Pseudomonas aeruginosa; Respiratory Tract Infections; Sequence Analysis, DNA; Young Adult | 2016 |
Effect of Antimicrobial Consumption and Production Type on Antibacterial Resistance in the Bovine Respiratory and Digestive Tract.
Topics: Agriculture; Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Respiratory Tract Infections | 2016 |
Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Turkey; Young Adult | 2016 |
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Drug Administration Routes; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Models, Theoretical; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2016 |
Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
Topics: Acetylcysteine; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Drug Combinations; Drug Interactions; Enterobacter cloacae; Ertapenem; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Thienamycins | 2016 |
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Monte Carlo Method; Otitis Media; Respiratory Tract Infections | 2008 |
[Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Bone Diseases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation; Drug Resistance, Bacterial; Forecasting; Humans; Injections, Intravenous; Macrolides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Risk Factors; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2008 |
Beta-lactam effects on mixed cultures of common respiratory isolates as an approach to treatment effects on nasopharyngeal bacterial population dynamics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cells, Cultured; Clavulanic Acid; Computer Simulation; Haemophilus influenzae; Nasopharynx; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
[Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases].
Topics: beta-Lactams; Child; Child, Preschool; Dosage Forms; Drug Resistance, Bacterial; Humans; Otitis Media; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome; Urinary Tract Infections | 2008 |
[Analysis on the sensitivity to beta-lactam antibiotics of respiratory-infectious isolates on the second survey on the sensitivity of isolates conducted by the Japanese Society of Chemotherapy in 2007--concerning the aspect of PK/PD break points].
Topics: Adult; Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactams; Dose-Response Relationship, Drug; Humans; Japan; Respiratory Tract Infections; Societies, Medical; Time Factors | 2009 |
In vitro interference of beta-lactams with biofilm development by prevalent community respiratory tract isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Biofilms; Genotype; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Respiratory System; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Respiratory Tract Infections; Sequence Analysis, DNA | 2012 |
GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues.
Topics: Aged, 80 and over; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalytic Domain; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Humans; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Respiratory Tract Infections | 2013 |
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Europe; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2003 |
[Role of demand in the prescription of antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Prescriptions; Drug Resistance, Bacterial; Humans; Macrolides; Respiratory Tract Infections; Self Medication; Spain | 2003 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
The in vitro effects of faropenem on lower respiratory tract pathogens isolated in the United Kingdom.
Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 2003 |
Comparative in vitro activity of telithromycin and beta-lactam antimicrobials against community-acquired bacterial respiratory tract pathogens in the United States: findings from the PROTEKT US study, 2000-2001.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; In Vitro Techniques; Ketolides; Macrolides; Microbial Sensitivity Tests; Multicenter Studies as Topic; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; United States | 2004 |
In vitro activity of ertapenem against selected respiratory pathogens.
Topics: Bacteria; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 2004 |
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Humans; Italy; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus | 2004 |
[Activity of ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Drug Resistance, Multiple, Bacterial; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Spain; Streptococcus pneumoniae | 2005 |
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Respiratory Tract Infections; Streptococcus pneumoniae | 2005 |
Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Bronchitis, Chronic; Drug Resistance, Multiple, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Otitis Media, Suppurative; Respiratory Tract Infections; Sinusitis; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens.
Topics: Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrolides; Microbial Sensitivity Tests; Models, Biological; Respiratory Tract Infections | 2005 |
Antibacterial activity of propolis and its active principles alone and in combination with macrolides, beta-lactams and fluoroquinolones against microorganisms responsible for respiratory infections.
Topics: Anti-Infective Agents; Bacteria; beta-Lactams; Drug Therapy, Combination; Fluoroquinolones; Haemophilus influenzae; Humans; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Propolis; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae | 2006 |
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
Topics: Adolescent; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Macrolides; Male; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Phylogeny; Pneumococcal Infections; Polymerase Chain Reaction; Respiratory Tract Infections; Sequence Analysis, DNA; Serotyping; Streptococcus pneumoniae | 2007 |
Prescribing antibiotics in primary care.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Humans; Respiratory Tract Infections | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
[Susceptibility to betalactam antibiotics, glycopeptides and aminoglycosides in commensal strains of erythromycin-resistant alpha-hemolytic streptococci and Gemella spp].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Hemolysin Proteins; Humans; Lung Abscess; Microbial Sensitivity Tests; Pharyngitis; Respiratory Tract Infections; Staphylococcaceae; Streptococcal Infections; Streptococcus | 2008 |
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Bacterial infections of the upper respiratory airways and beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Humans; Laryngitis; Otitis Media; Pharyngitis; Respiratory Tract Infections; Rhinitis; Sinusitis | 1984 |
Beta-lactam antibiotics in lower respiratory tract infections.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchitis; Humans; Penicillins; Pneumonia; Respiratory Tract Infections | 1984 |
Clavulanic acid and respiratory infection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Humans; Respiratory Tract Infections | 1981 |
[Respiratory tract infection with Branhamella catarrhalis].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Neisseriaceae; Respiratory Tract Infections | 1982 |
Susceptibility of Legionella sp. and nosocomial respiratory tract isolates of Enterobacteriaceae to Sch 29482 and other beta-lactam agents.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Enterobacteriaceae; Humans; Lactams; Legionella; Microbial Sensitivity Tests; Respiratory Tract Infections | 1982 |
Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
Topics: Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Streptococcus | 1997 |
[Significant role of penem antibiotics: focused on faropenem (discussion)].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1997 |
Antibiotic resistance and prevalence of beta-lactamase in Haemophilus influenzae isolates-a surveillance study of patients with respiratory infection in Saudi Arabia.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; beta-Lactams; Chloramphenicol; Community-Acquired Infections; Conjunctiva; Drug Resistance, Microbial; Ear, Middle; Female; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Nasal Lavage Fluid; Prevalence; Respiratory Tract Infections; Roxithromycin; Saudi Arabia; Serotyping; Sputum; Tetracycline | 2000 |
[Prescription of beta-lactams for community-acquired broncho-pulmonary infections in adults. Observations in the hospital environment].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Costs; Drug Prescriptions; Female; Hospitalization; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections | 2000 |
In vitro activity of faropenem against respiratory pathogens.
Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2002 |
Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Administration Schedule; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Models, Biological; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Time Factors | 2002 |
Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.
Topics: Aged; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Humans; Male; Middle Aged; Neisseriaceae; Penicillinase; Respiratory Tract Infections | 1978 |
Transfer of beta-lactam preparations created in Japan to lung tissue and the drug selection for chemotherapy of respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Blood Proteins; Bronchi; Female; Half-Life; Humans; Infusions, Intravenous; Japan; Lung; Lung Neoplasms; Male; Middle Aged; Protein Binding; Respiratory Tract Infections | 1992 |
In-vitro antimicrobial activity of the penem BRL-42715, alone and in combination with ampicillin, against respiratory tract pathogens.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Humans; Lactams; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus | 1992 |
Beta-lactam resistance in Neisseria spp.
Topics: Anti-Bacterial Agents; beta-Lactams; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Neisseria; Respiratory Insufficiency; Respiratory Tract Infections | 1990 |
[Comparison of in vitro activity of 4 oral beta-lactams on microorganisms responsible for broncho-pulmonary infections in children].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Escherichia coli; Haemophilus influenzae; Humans; In Vitro Techniques; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Tract Infections | 1988 |
Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Female; Humans; Infant; Male; Neisseriaceae; Penicillins; Respiratory Tract Infections | 1986 |
[In vitro susceptibility of bacterial isolates from patients with respiratory tract infections to beta-lactam antibiotics].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus | 1986 |
[In vitro susceptibility, of bacterial isolates from patients with respiratory tract infections, to beta-lactam antibiotics II].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Microbial; Humans; Klebsiella; Pseudomonas; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus | 1986 |
The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Pseudomonas Infections; Respiratory Tract Infections | 1985 |